Abstract
Lifestyle modification is primary in cardiovascular (CV) disease prevention. A major contribution is the Mediterranean diet (MedDiet), defined by two of seven components. Italian investigators determined a significant decrease in peripheral arterial disease of 56 % for a high score. Multiple specific CV risk factors are also favorably modified by the MedDiet. This includes beneficial effect on inflammation, vascular endothelium, and insulin resistance. There is also evidence that coronary heart disease, diabetes mellitus, and metabolic syndrome are decreased. Benefit appears to extend to new migrants in France. The economics of dietary adherence are favorable with decreased total lifetime health costs. Although mixed nuts appear to be a major factor in the MedDiet, special emphasis goes to extra virgin olive oil. Benefit also extends to other noncommunicable diseases with a decrease in cancer, Parkinson’s disease, and Alzheimer’s disease. Further quantitation of benefit and understanding of mechanisms involved in dietary benefit is essential.
This is a preview of subscription content, access via your institution.
Abbreviations
- apoB:
-
apolipoprotein B
- CHD:
-
Coronary heart disease
- CI:
-
Confidence interval
- CV:
-
Cardiovascular
- DM:
-
Diabetes mellitus
- HbA1c:
-
Glycated hemoglobin
- HDL-C:
-
High-density lipoprotein cholesterol
- HOMA-IR:
-
Homeostatic model assessment-insulin resistance
- HR:
-
Hazard ratio
- LDL-C:
-
Low-density lipoprotein cholesterol
- MedDiet:
-
Mediterranean diet
- MI:
-
Myocardial infarction
- MetSyn:
-
Metabolic syndrome
- PAD:
-
Peripheral arterial disease
- PREDIMED:
-
Prevención con Dieta Mediterránea
- RR:
-
Relative risk
- VLDL-C:
-
Very low-density lipoprotein cholesterol
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Rees K, Hartley L, Flowers N, et al. ‘Mediterranean’ dietary pattern for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;8, CD009825. This article by Rees et al. is an excellent initial reference that gives background information starting with the Seven Countries study and then goes on to define the MedDiet.
Bautista MC, Engler MM. The Mediterranean diet: is it cardioprotective? Prog Cardiovasc Nurs. 2005;20(2):70–6.
Ruiz-Canela M, Estruch R, Corella D, et al. Association of Mediterranean diet with peripheral artery disease: the PREDIMED randomized trial. JAMA. 2014;311(4):415–7.
Martinez-Gonzalez MA, Corella D, Salas-Salvado J, et al. Cohort profile: design and methods of the PREDIMED study. Int J Epidemiol. 2012;41(2):377–85. This description of the PREDIMED study is key in assessing the current status of the MedDiet.
Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279–90. Estruch et al. define the importance of extra virgin olive oil and/or mixed nuts assessed as supplements to the MedDiet.
Estruch R, Martinez-Gonzalez MA, Corella D, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006;145(1):1–11.
Sala-Vila A, Romero-Mamani ES, Gilabert R, et al. Changes in ultrasound-assessed carotid intima-media thickness and plaque with a mediterranean diet: a substudy of the PREDIMED trial. Arterioscler Thromb Vasc Biol. 2014;34(2):439–45.
Bach A, Serra-Majem L, Carrasco JL, et al. The use of indexes evaluating the adherence to the Mediterranean diet in epidemiological studies: a review. Public Health Nutr. 2006;9(1A):132–46.
Ciccarone E, Di Castelnuovo A, Salcuni M, et al. A high-score Mediterranean dietary pattern is associated with a reduced risk of peripheral arterial disease in Italian patients with Type 2 diabetes. J Thromb Haemost. 2003;1(8):1744–52.
Willett WC. The Mediterranean diet: science and practice. Public Health Nutr. 2006;9(1A):105–10.
Nordmann AJ, Suter-Zimmermann K, Bucher HC, et al. Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors. Am J Med. 2011;124(9):841–51. e2.
Martinez-Gonzalez MA, de la Fuente-Arrillaga C, Lopez-Del-Burgo C, et al. Low consumption of fruit and vegetables and risk of chronic disease: a review of the epidemiological evidence and temporal trends among Spanish graduates. Public Health Nutr. 2011;14(12A):2309–15.
Sofi F. The Mediterranean diet revisited: evidence of its effectiveness grows. Curr Opin Cardiol. 2009;24(5):442–6.
Estruch R, Martinez-Gonzalez MA, Corella D, et al. Effects of dietary fibre intake on risk factors for cardiovascular disease in subjects at high risk. J Epidemiol Community Health. 2009;63(7):582–8.
Nordmann A. Mediterranean or low-fat diets to reduce cardiovascular risk? Praxis (Bern 1994). 2011;100(21):1283–8.
Grosso G, Mistretta A, Frigiola A, et al. Mediterranean diet and cardiovascular risk factors: a systematic review. Crit Rev Food Sci Nutr. 2014;54(5):593–610. This reference by Grosso et al. is important in assessing the epidemiological evidence for the role of the MedDiet in CV disease prevention.
Serra-Majem L, Roman B, Estruch R. Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev. 2006;64(2 Pt 2):S27–47.
Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr. 2010;92(5):1189–96.
Fernandez LC, Serra JD, Alvarez JR, et al. Dietary fats and cardiovascular health. Aten Primaria. 2011;43(3):157 e1–16.
Benito M, Oria R, Sanchez-Gimeno AC. Characterization of the olive oil from three potentially interesting varieties from Aragon (Spain). Food Sci Technol Res. 2010;16(6):523–30.
Van Horn L, McCoin M, Kris-Etherton PM, et al. The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc. 2008;108(2):287–331.
Babio N, Bullo M, Salas-Salvado J. Mediterranean diet and metabolic syndrome: the evidence. Public Health Nutr. 2009;12(9A):1607–17.
Kastorini CM, Milionis HJ, Goudevenos JA, Panagiotakos DB. Mediterranean diet and coronary heart disease: is obesity a link? - A systematic review. Nutr Metab Cardiovasc Dis. 2010;20(7):536–51.
Richard C, Couture P, Ooi EM, et al. Effect of mediterranean diet with and without weight loss on apolipoprotein b100 metabolism in men with metabolic syndrome. Arterioscler Thromb Vasc Biol. 2014;34(2):433–8.
Kastorini CM, Milionis HJ, Esposito K, et al. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol. 2011;57(11):1299–313.
Champagne CM. The usefulness of a Mediterranean-based diet in individuals with type 2 diabetes. Curr Diab Rep. 2009;9(5):389–95.
Esposito K, Maiorino MI, Ceriello A, Giugliano D. Prevention and control of type 2 diabetes by Mediterranean diet: a systematic review. Diabetes Res Clin Pract. 2010;89(2):97–102.
Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr. 2013;97(3):505–16.
Lasa A, Miranda J, Bullo M, et al. Comparative effect of two Mediterranean diets versus a low-fat diet on glycaemic control in individuals with type 2 diabetes. Eur J Clin Nutr 2014. doi:10.1038/ejcn.2014.1.
Darmon N, Khlat M. An overview of the health status of migrants in France, in relation to their dietary practices. Public Health Nutr. 2001;4(2):163–72.
Mead A, Atkinson G, Albin D, et al. Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease - evidence from systematic reviews of randomized controlled trials (second update, January 2006). J Hum Nutr Diet. 2006;19(6):401–19.
Hooper L. Primary prevention of CVD: diet and weight loss. Clin Evid (Online). 2007;2007:0219.
Badimon L, Vilahur G, Padro T. Nutraceuticals and atherosclerosis: human trials. Cardiovasc Ther. 2010;28(4):202–15.
Von Schacky C. Coronary artery disease. Dtsch Med Wochenschr. 2002;127(46):2429–31.
Saulle R, Semyonov L, La Torre G. Cost and cost-effectiveness of the Mediterranean diet: results of a systematic review. Nutrients. 2013;5(11):4566–86.
Perez-Jimenez F, AlvarezdeCienfuegos G, Badimon L, et al. International conference on the healthy effect of virgin olive oil. Eur J Clin Investig. 2005;35(7):421–4.
Faine LA, Rodrigues HG, Galhardi CM, et al. Effects of olive oil and its minor constituents on serum lipids, oxidative stress, and energy metabolism in cardiac muscle. Can J Physiol Pharmacol. 2006;84(2):239–45.
Brzosko S, De Curtis A, Murzilli S, et al. Effect of extra virgin olive oil on experimental thrombosis and primary hemostasis in rats. Nutr Metab Cardiovasc Dis. 2002;12(6):337–42.
Tyrovolas S, Panagiotakos DB. The role of Mediterranean type of diet on the development of cancer and cardiovascular disease, in the elderly: a systematic review. Maturitas. 2010;65(2):122–30.
Proietti AR, del Balzo V, Dernini S, et al. Mediterranean diet and prevention of non-communicable diseases: scientific evidences. Ann Ig. 2009;21(3):197–210.
Compliance with Ethics Guidelines
Conflict of Interest
Thomas F. Whayne, Jr. declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Ischemic Heart Disease
Rights and permissions
About this article
Cite this article
Whayne, T.F. Ischemic Heart Disease and the Mediterranean Diet. Curr Cardiol Rep 16, 491 (2014). https://doi.org/10.1007/s11886-014-0491-6
Published:
DOI: https://doi.org/10.1007/s11886-014-0491-6
Keywords
- Cardiovascular risk
- Coronary heart disease
- Ischemic heart disease
- Lipoproteins
- Mediterranean diet
- Metabolic syndrome
- Myocardial infarction
- Peripheral arterial disease